Article info

Original research
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

Authors

  1. Correspondence to Dr Pablo Nenclares; pablo.nenclares{at}icr.ac.uk
View Full Text

Citation

Nenclares P, Gunn L, Soliman H, et al
On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

Publication history

  • Accepted May 6, 2021
  • First published June 8, 2021.
Online issue publication 
June 08, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.